NI-57,1883548-89-7

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

NI-57

CAS No. : 1883548-89-7

MCE 国际站：NI-57

产品活性：NI-57 为溴结构域和植物同源锌指结构域 (BRPF) 蛋白家族的抑制剂，对 BRPF1，BRPF2 (BRD1) 和 BRPF3 的 IC₅₀ 值分别为 3.1，46 和 140 nM。

研究领域：Epigenetics

作用靶点：Epigenetic Reader Domain

In Vitro: NI-57 is an inhibitor of bromodomain and plant homeodomain finger-containing (BRPF), with IC₅₀s of 3.1, 46 and 140 nM for BRPF1, BRPF2 (BRD1) and BRPF3, respectively. NI-57 binds the BRD of BRPF1 with a K_d of 31 ± 2 nM, BRD1 with a K_d of 110 ± 13 nM, and BRPF3 with a K_d of 410 ± 47 nM, whereas binding to BRD9 is weaker (K_d 1000 ± 130 nM) measured by isothermal titration calorimetry. NI-57 shows less active effect on BRD9 (IC₅₀, 520 nM) and BRD4 (BD1) (IC₅₀, 3700 nM), TRIM24 (IC₅₀, 1600 nM). NI-57 also inhibits BRPF BRDs in the nucleus, but shows little effect on the proliferation of many cancer cell lines with GI₅₀s of 10.4 μM (NCI-H1703 cells), 14.7 μM (DMS114), 15.6 μM (HRA-19), and 16.6 μM (RERF-LC-Sq1). Furthermore, Inhibition on BRPF1 of NI-57 (10 μM) reduces the gene expression of CCL-22 by 27.7 ± 9.4%.

In Vivo: NI-57 has favorable oral bioavailability in mice.

相关产品：Bioactive Compound Library Plus  |  Epigenetics Compound Library  |  Immunology/Inflammation Compound Library  |  Histone Modification Research Compound Library  |  Anti-Cancer Compound Library  |  Reprogramming Compound Library  |  Chemical Probe Library  |  Anti-Blood Cancer Compound Library  |  (+)-JQ-1  |  Curcumin  |  A-485  |  C646  |  Revumenib  |  BRM/BRG1 ATP Inhibitor-1  |  BI 2536  |  dBET6  |  MZ 1  |  ARV-825  |  Inobrodib  |  Birabresib  |  666-15  |  SGC-CBP30  |  VTP50469  |  ACBI1  |  AU-15330  |  ARV-771  |  I-BET151  |  dBET1  |  dCBP-1  |  ABBV-744  |  Anacardic Acid  |  Molibresib  |  NSC 228155  |  KG-501  |  A-366  |  FHD-286  |  Mivebresib

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds